New lung reconditioning devices could save more donor organs
NCT ID NCT07361718
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests two medical devices that recondition donor lungs outside the body before transplant. The goal is to see which device helps more marginal donor lungs become healthy enough for transplant. Twenty adults awaiting double lung transplant will take part. If one device works better, it could increase the number of usable donor lungs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ex vivo lung perfusion device (XPS XVIVO or OCS Transmedics)
- What this could lead to
- If successful, this could help more donor lungs become suitable for transplant, potentially reducing waitlist deaths.
- What could go wrong
- This is a very small pilot study with only 20 participants, so results may not apply broadly. The devices may not improve outcomes enough to change practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Irccs Aoubo
Bologna, BO, 40138, Italy